Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$5.35 - $7.11 $144,535 - $192,083
-27,016 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$4.36 - $7.94 $117,789 - $214,507
27,016 New
27,016 $150,000
Q4 2018

Feb 13, 2019

SELL
$6.15 - $10.51 $62,404 - $106,644
-10,147 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$10.32 - $13.06 $104,717 - $132,519
10,147 New
10,147 $108,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $157M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Element Capital Management LLC Portfolio

Follow Element Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Element Capital Management LLC with notifications on news.